1
Kevin Rodzinak
DUDKIN Vadim, FRALEY Mark E, ARRINGTON Kenneth L, LAYTON Mark E, RODZINAK Kevin J, PERO Joseph E, REIF Alexander J: Modulateurs allostériques positifs de mglur2, Positive allosteric modulators of mglur2. Merck Sharp & Dohme, DUDKIN Vadim, FRALEY Mark E, ARRINGTON Kenneth L, LAYTON Mark E, RODZINAK Kevin J, PERO Joseph E, REIF Alexander J, February 16, 2012: WO/2012/021382 (19 worldwide citation)

The present invention is directed to benzimidazolone derivatives which are positive allosteric modulators of the mGluR2 receptor, useful in the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction and diseases in which the mGluR2 receptor is involve ...


2
Eric First, M.D.
Eric R First: Botulinum toxin therapy for skin disorders. Allergan, Hal Gibson, Debra Condino, November 1, 2011: US08048423 (8 worldwide citation)

Methods for treating skin disorders by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a skin disorder.


3
Eric First, M.D.
Eric R First: Methods for treating eye disorders. Allergan, Claude L Nassif, Stephen Donovan, Martin Voet, December 16, 2008: US07465458 (6 worldwide citation)

The present invention provides methods of treating an eye disorder. The methods comprise a step of locally administering a Clostridial toxin to the eye of a patient to treat the disorder. The eye disorder may be associated with an inflammation of the eye, including for example, bacterial conjunctivi ...


4
Ethan Simon
John Robert Mattox, Ethan Scott Simon, Ramesh Balubhai Petigara: Stable microbicide formulation. Rohm and Haas Company, S Matthew Cairns, June 8, 1999: US05910503 (6 worldwide citation)

Stable microbicidal compositions containing a 3-isothiazolone compound, metal nitrate, bromic acid, iodic acid, periodic acid, or their salts and water are disclosed. Also disclosed are methods of preventing or reducing precipitate formation in 3-isothiazolone compositions.


5

6

7

8
Kevin Rodzinak
Jeannie M Arruda, Brian T Campbell, Nicholas D P Cosford, Jacob M Hoffman, Essa H Hu, Mark E Layton, Yiwei Li, Jun Liang, Kevin J Rodzinak, Tony Siu, Brian A Stearns, Lida R Tehrani, Mark T Bilodeau, Peter J Manley: Inhibitors of Akt activity. Merck Sharp & Dohme, Matthew A Leff, David A Muthard, March 22, 2011: US07910561 (1 worldwide citation)

The present invention is directed to compounds which contain substituted naphthyridines which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer ...


9
Lee Minus Parson
Foscante Raymond Eugene, Stevens Charles David, Parson Lee Minus: Organotin acrylate and organotin polysiloxane antifouling coating composition.. Ameron, September 2, 1987: EP0234822-A2 (1 worldwide citation)

The invention provides a marine antifouling coating composition comprising a tributyltin acrylate coresin in the range of from about 10% to about 25% by weight, a tributyltin polysiloxane coresin in the range of from about 2% to about 20% by weight, at least one filler in the range of from about 10% ...


10
Eric First, M.D.
Eric First: Botulinum toxin therapy for skin disorders. Allergan, Brigitte C Phan, Ted Chan, Debra Condino, October 28, 2014: US08871224

Methods for treating skin disorders by local administration of a Clostridial toxin, such as a botulinum toxin, to a patient with a skin disorder.



Click the thumbnails below to visualize the patent trend.